ArticleInternational journal of ophthalmology2016

Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia.

Christos Chryssafis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.